Unveiling the therapeutic potential of Dl-3-n-butylphthalide in NTG-induced migraine mouse: activating the Nrf2 pathway to alleviate oxidative stress and neuroinflammation
ConclusionsOur data suggest that NBP may alleviate migraine by activating the Nrf2 pathway to reduce oxidative stress and inflammation in migraine mouse models, confirming that it may be a potential drug for the treatment of migraine.Graphical Abstract
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research
More News: Anxiety | Back Pain | Brain | Chronic Pain | Genetics | Headache | Migraine | Neurology | Nitroglycerin | Pain